RM Global Partners

Profile

RM Global Partners is a global life science investment banking and strategic advisory firm headquartered in New York, established with a focus on life sciences including biopharma, biotech, medical devices, consumer/digital health, and diagnostics. The firm's team includes Managing Directors such as Assaf Keret and Yaron Breski, who bring over 13 years of experience in financial consulting and healthcare, respectively. They provide services such as M&A, private equity financing, valuation advice, corporate venture capital management, and strategic consulting.

RM Global Partners invests primarily in the life sciences sector, targeting innovative companies in biopharma and medical devices at early and venture stages. Their notable investment vehicles include the RMGP BioPharma Fund and the Global BioAccess Fund, focusing on North America, the EU, and Israel. RM Global Partners also engages in partnerships with several global platforms, expanding its reach across various regions, including Asia. The firm is involved in facilitating technology transfer and portfolio enhancement initiatives.

RM Global has a diverse portfolio of investments, with notable companies focusing on addressing unmet medical needs in oncology, CNS disorders, cardiology, and rare diseases. Through strategic initiatives, the firm seeks to support ventures preparing for or conducting clinical trials, leveraging its extensive network in the life sciences industry.